Cascade Financial Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$280K Hold
3,051
0.02% 235
2026
Q1
$260K Sell
3,051
-730
-19% -$65.1K 0.03% 222
2025
Q4
$299K Sell
3,781
-854
-18% -$67K 0.03% 207
2025
Q3
$371K Buy
4,635
+20
+0.4% +$1.71K 0.04% 187
2025
Q2
$420K Hold
4,615
0.05% 173
2025
Q1
$432K Hold
4,615
0.05% 166
2024
Q4
$420K Sell
4,615
-250
-5% -$23.9K 0.05% 152
2024
Q3
$485K Sell
4,865
-200
-4% -$20.4K 0.06% 143
2024
Q2
$492K Buy
5,065
+100
+2% +$9.22K 0.06% 141
2024
Q1
$426K Buy
+4,965
New +$421K 0.06% 145

Other funds holding CL

Cascade Financial Partners's CL Position: Q2 2026 in Review

Cascade Financial Partners held its Colgate-Palmolive (CL) position steady in Q2 2026 at 3,051 shares worth $280K. The position accounts for 0.02% of the portfolio, ranked #235.

Cascade Financial Partners first reported a position in CL in Q1 2024 and has held it in 10 quarters since. The position peaked at $492K in Q2 2024. 2,025 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Cascade Financial Partners held 3,051 shares of Colgate-Palmolive worth $280K as of Q2 2026.
  • Cascade Financial Partners left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.02% of Cascade Financial Partners's portfolio in Q2 2026, its #235 holding.
  • Cascade Financial Partners first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 10 quarters since.
  • Cascade Financial Partners's Colgate-Palmolive position peaked at $492K in Q2 2024.
  • 2,025 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Cascade Financial Partners's 13F filing for Q2 2026, filed 4 Aug 2026.